Edwards Lifesciences Corporation
US ˙ NYSE ˙ US28176E1082

SecurityEW / Edwards Lifesciences Corporation
InstitutionWetherby Asset Management Inc
Latest Disclosed Ownership7,732 shares
Latest Disclosed Value $ 601,318
Wetherby Asset Management Inc reports 0.10% increase in ownership of EW / Edwards Lifesciences Corporation

On November 14, 2025 - Wetherby Asset Management Inc filed a 13F-HR form disclosing ownership of 7,732 shares of Edwards Lifesciences Corporation (US:EW) valued at $601,318 USD as of September 30, 2025. The entity filed a previous 13F-HR on August 14, 2025 disclosing 7,724 shares of Edwards Lifesciences Corporation. This represents a change in shares of 0.10% during the quarter. The current value of the position is $664,643 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date		 Effective
Date		Form Security Class ID Avg Price
Paid (Est)		 Reported
Shares		 ΔShares ΔShares
(%)		 Reported
Value
(x1000)		 ΔValue
(%)		 Alloc
(%)		 ΔAlloc ΔAlloc (%) Cost Basis
(x1000)		 Unrealized
Gain/Loss
(x1000)
2025-11-14 2025-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 7,732 8 0.10 601 -0.50 0.0245
2025-08-14 2025-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 7,724 -612 -7.34 604 -2.11 0.0269
2025-02-14 2024-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 8,336 -530 -5.98 617 5.47 0.0296
2024-11-14 2024-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 8,866 -2,460 -21.72 585 -44.07 0.0268
2024-08-14 2024-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 11,326 -251 -2.17 1,046 -5.42 0.0493
2024-05-15 2024-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,577 226 1.99 1,106 27.86 0.0527
2024-02-14 2023-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,351 -95 -0.83 866 9.22 0.0451
2023-11-14 2023-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 11,446 -3,216 -21.93 793 -42.73 0.0450
2023-08-14 2023-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 14,662 -675 -4.40 1,383 9.07 0.0745
2023-05-12 2023-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 15,337 2,547 19.91 1,269 32.91 0.0743
2023-02-14 2022-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 12,790 -858 -6.29 954 -15.43 0.0613
2022-11-14 2022-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 13,648 1,651 13.76 1,128 -1.14 0.0795
2022-08-15 2022-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 11,997 -921 -7.13 1,141 -24.98 0.0779
2022-05-16 2022-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 12,918 -333 -2.51 1,521 -11.42 0.0872
2022-02-14 2021-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 13,251 721 5.75 1,717 21.00 0.0964
2021-11-15 2021-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 12,530 265 2.16 1,419 11.73 0.0876
2021-08-16 2021-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 12,265 621 5.33 1,270 30.52 0.0775
2021-05-14 2021-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 11,644 -514 -4.23 973 -12.26 0.0742
2021-02-11 2020-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 12,158 11,363 1,429.31 1,109 1,660.32 0.0752
2020-12-16 2020-09-30 13F/A-01 EDWARDS LIFESCIENCES COM 28176E108 10,926 -1,150 872 0.0799
2020-12-16 2020-09-30 13F/A-02 EDWARDS LIFESCIENCES COM 28176E108 795 -11,281 -93.42 63 -92.45 0.1893
2020-11-13 2020-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 12,138 62 969 61,636.9084
2020-08-14 2020-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 12,076 8,567 244.14 834 25.98 0.0791
2020-05-06 2020-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,509 -142 -3.89 662 -22.30 0.0743
2020-01-28 2019-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,651 111 3.14 852 9.37 0.0839
2019-10-31 2019-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,540 240 7.27 779 27.70 0.0813
2019-07-25 2019-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 3,300 27 0.82 610 -2.56 0.0668
2019-07-25 2019-03-31 13F/A-1 EDWARDS LIFESCIENCES COM 28176E108 3,273 337 11.48 626 39.11 0.0780
2019-05-09 2019-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 3,273 337 626
2019-01-30 2018-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,936 756 34.68 450 18.73 0.0637
2018-11-07 2018-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,180 -45 -2.02 379 17.34 0.0468
2018-07-24 2018-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 2,225 50 2.30 323 6.60 0.0437
2018-05-04 2018-03-31 13F EDWARDS LIFESCIENCES COM 28176E108 2,175 264 13.81 303 40.93 0.0418
2018-02-09 2017-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 1,911 23 1.22 215 4.37 0.0298
2017-11-13 2017-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 1,888 149 8.57 206 0.00 0.0306
2017-08-01 2017-06-30 13F EDWARDS LIFESCIENCES COM 28176E108 1,739 1,739 206 0.0350
2017-02-08 2016-12-31 13F EDWARDS LIFESCIENCES COM 28176E108 0 -1,957 -100.00 0 -100.00
2016-11-14 2016-09-30 13F EDWARDS LIFESCIENCES COM 28176E108 1,957 1,957 236 0.0477
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.